SI-BONE To Report Third Quarter 2020 Financial Results on November 2, 2020
SANTA CLARA, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving […]
ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program
ORIC-114 is a potential best-in-class inhibitor designed for brain penetrance and selectivity for exon 20 insertion mutations of EGFR and […]
EMCORE Corporation Announces Preliminary Financial Results for the Fourth Fiscal Quarter Ended September 30, 2020
ALHAMBRA, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that […]
Asure Software Announces Timing of Third Quarter 2020 Financial Results
AUSTIN, Texas, Oct. 19, 2020 (GLOBE NEWSWIRE) — Asure (NASDAQ:ASUR), a leading provider of cloud-based Human Capital Management (HCM) software […]
Replimune Appoints Tanya Lewis to the Board of Directors
WOBURN, Mass., Oct. 19, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies […]
